Natalia V. Demakova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Natalia V. Demakova has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Dmitriy Yur'Evich Ivkin
Center of Experimental Pharmacology, St. Petersburg State Chemical Pharmaceutical University, 14 Prof. Popov Str., 197022 Saint-Petersburg, Russia
5 shared publications - Marina V. Krasnova
Saint-Petersburg State Chemical and Pharmaceutical University
3 shared publications - E. D. Semivelichenko
Saint-Petersburg State Chemical and Pharmaceutical University
2 shared publications - G. A. Plisko
Saint-Petersburg State Chemical and Pharmaceutical University
2 shared publications - Sergey Vladimirovich Okovityi
Saint Petersburg State Chemical and Pharmaceutical University; Saint Petersburg State University
2 shared publications - A. N. Kulikov
First Pavlov State Medical University of St. Petersburg
1 shared publication
Latest Publications
- Open Access
Effect of Phytopreparations Based on Bioreactor-Grown Cell Biomass of Dioscorea deltoidea, Tribulus terrestris and Panax japonicus on Carbohydrate and Lipid Metabolism in Type 2 Diabetes Mellitus
In the present study, we explored the therapeutic potential of bioreactor-grown cell cultures of the medicinal plant species Dioscorea deltoidea, Tribulus terrestris and Panax japonicus to treat carbohydrate metabolism disorders (CMDs) in laboratory rats. In the adrenaline model of hyperglycemia, aqueous suspensions of cell biomass pre-administered at a dose of 100 mg dry biomass/kg significantly reduced glucose level in animal blood 1–2.5 h (D. deltoidea and T. terrestris) or 1 h (P. japonicus) after adrenaline hydrochloride administration. In a streptozotocin-induced model of type 2 diabetes mellitus, the cell biomass of D. deltoidea and T. terrestris acted towards normalization of carbohydrate and lipid metabolism, as evidenced by a significant reduction of daily diuresis (by 39–57%), blood-glucose level (by 46–51%), blood content in urine (by 78–80%) and total cholesterol (25–36%) compared to animals without treatment. Bioactive secondary metabolites identified in the cell cultures and potentially responsible for their actions were deltoside, 25(S)-protodioscin and protodioscin in D. deltoidea; furostanol-type steroidal glycosides and quinic acid derivatives in T. terrestris; and ginsenosides and malonyl-ginsenosides in P. japonicus. These results evidenced for high potential of bioreactor-grown cell suspensions of these species for prevention and treatment of CMD, which requires further investigation.
Open AccessEffect of Phytopreparations Based on Bioreactor-Grown Cell Biomass of Dioscorea deltoidea, Tribulus terrestris and Panax japonicus on Carbohydrate and Lipid Metabolism in Type 2 Diabetes Mellitus
In the present study, we explored the therapeutic potential of bioreactor-grown cell cultures of the medicinal plant species Dioscorea deltoidea, Tribulus terrestris and Panax japonicus to treat carbohydrate metabolism disorders (CMDs) in laboratory rats. In the adrenaline model of hyperglycemia, aqueous suspensions of cell biomass pre-administered at a dose of 100 mg dry biomass/kg significantly reduced glucose level in animal blood 1–2.5 h (D. deltoidea and T. terrestris) or 1 h (P. japonicus) after adrenaline hydrochloride administration. In a streptozotocin-induced model of type 2 diabetes mellitus, the cell biomass of D. deltoidea and T. terrestris acted towards normalization of carbohydrate and lipid metabolism, as evidenced by a significant reduction of daily diuresis (by 39–57%), blood-glucose level (by 46–51%), blood content in urine (by 78–80%) and total cholesterol (25–36%) compared to animals without treatment. Bioactive secondary metabolites identified in the cell cultures and potentially responsible for their actions were deltoside, 25(S)-protodioscin and protodioscin in D. deltoidea; furostanol-type steroidal glycosides and quinic acid derivatives in T. terrestris; and ginsenosides and malonyl-ginsenosides in P. japonicus. These results evidenced for high potential of bioreactor-grown cell suspensions of these species for prevention and treatment of CMD, which requires further investigation.
- 1 January 2021
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 9 (1)
Efficacy of empagliflozine in experimental chronic heart failure in normoglycemia
Эффективность эмпаглифлозина при экспериментальной хронической сердечной недостаточности в условиях нормогликемии
- 1 January 2021
- Published by Geotar-Media Publishing Group in Cardiology: News, Opinions, Training
- Vol. 9 (1)
Efficacy of empagliflozine in experimental chronic heart failure in normoglycemia
Эффективность эмпаглифлозина при экспериментальной хронической сердечной недостаточности в условиях нормогликемии